[{"id":"bd0915a0-fd20-4277-b54e-97bf1a6410c3","acronym":"","url":"https://clinicaltrials.gov/study/NCT03452774","created_at":"2021-01-18T17:01:36.578Z","updated_at":"2024-07-02T16:35:14.464Z","phase":"","brief_title":"SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry","source_id_and_acronym":"NCT03452774","lead_sponsor":"Massive Bio, Inc.","biomarkers":" EGFR • HER-2 • PD-L1 • KRAS • BRAF • ER • ALK • TP53 • TMB • FLT3 • ABL1 • NRAS • BRCA1 • BRCA2 • FGFR2 • PTEN • ROS1 • IDH1 • NTRK1 • BCL2 • IDH2 • NTRK3 • NTRK2 • STK11 • NPM1 • HRAS • DNMT3A • ERBB3 • RB1 • CLDN18 • PDGFRA • NF1 • JAK2 • NRG1 • POLE • AKT1 • PD-1 • CCND1 • MCL1 • KDR • PBRM1 • BAP1 • VEGFA • BCL6 • PDGFRB • PTCH1 • FGFR4 • MSH6 • CDK4 • MSH2 • CTNNB1 • MAP2K2 • FBXW7 • WT1 • ATRX • BRCA • RAF1 • TSC2 • CHEK2 • PD-L2 • ERBB4 • JAK1 • FANCA • TSC1 • MDM4 • POLD1 • CDK6 • CEBPA • PARP1 • AURKA • JAK3 • RICTOR • CHEK1 • GATA6 • MSH3 • TGFBR2 • GNAS • MYCL • AKT2 • CCND2 • CCND3 • CSF1R • MAP3K1 • ERCC4 • HDAC1 • PRDM1 • ZNF217 • CDKN1A • GATA3 • PARP2 • PARP3 • SDHA • ACVR1B • ZNF703","pipe":" | ","alterations":" HER-2 mutation • BAP1 mutation • AKT1 mutation • FGFR3 fusion • JAK3 mutation","tags":["EGFR • HER-2 • PD-L1 • KRAS • BRAF • ER • ALK • TP53 • TMB • FLT3 • ABL1 • NRAS • BRCA1 • BRCA2 • FGFR2 • PTEN • ROS1 • IDH1 • NTRK1 • BCL2 • IDH2 • NTRK3 • NTRK2 • STK11 • NPM1 • HRAS • DNMT3A • ERBB3 • RB1 • CLDN18 • PDGFRA • NF1 • JAK2 • NRG1 • POLE • AKT1 • PD-1 • CCND1 • MCL1 • KDR • PBRM1 • BAP1 • VEGFA • BCL6 • PDGFRB • PTCH1 • FGFR4 • MSH6 • CDK4 • MSH2 • CTNNB1 • MAP2K2 • FBXW7 • WT1 • ATRX • BRCA • RAF1 • TSC2 • CHEK2 • PD-L2 • ERBB4 • JAK1 • FANCA • TSC1 • MDM4 • POLD1 • CDK6 • CEBPA • PARP1 • AURKA • JAK3 • RICTOR • CHEK1 • GATA6 • MSH3 • TGFBR2 • GNAS • MYCL • AKT2 • CCND2 • CCND3 • CSF1R • MAP3K1 • ERCC4 • HDAC1 • PRDM1 • ZNF217 • CDKN1A • GATA3 • PARP2 • PARP3 • SDHA • ACVR1B • ZNF703"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 mutation • BAP1 mutation • AKT1 mutation • FGFR3 fusion • JAK3 mutation"],"overall_status":"Recruiting","enrollment":" Enrollment 50000","initiation":"Initiation: 01/01/2018","start_date":" 01/01/2018","primary_txt":" Primary completion: 12/01/2026","primary_completion_date":" 12/01/2026","study_txt":" Completion: 06/01/2027","study_completion_date":" 06/01/2027","last_update_posted":"2024-03-15"},{"id":"282ad5ed-28a5-4fcf-8a9b-672046063b64","acronym":"","url":"https://clinicaltrials.gov/study/NCT01059552","created_at":"2021-01-18T04:10:21.319Z","updated_at":"2024-07-02T16:36:53.163Z","phase":"Phase 1","brief_title":"Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)","source_id_and_acronym":"NCT01059552","lead_sponsor":"Fox Chase Cancer Center","biomarkers":" ERCC1 • HDAC1","pipe":" | ","alterations":" ERCC1 expression","tags":["ERCC1 • HDAC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ERCC1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • Zolinza (vorinostat)"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 12/16/2009","start_date":" 12/16/2009","primary_txt":" Primary completion: 07/22/2015","primary_completion_date":" 07/22/2015","study_txt":" Completion: 10/21/2019","study_completion_date":" 10/21/2019","last_update_posted":"2019-11-27"},{"id":"ac02c06d-b177-4fba-9873-0c26d5aba54f","acronym":"","url":"https://clinicaltrials.gov/study/NCT00788112","created_at":"2021-01-18T02:59:08.892Z","updated_at":"2024-07-02T16:37:19.139Z","phase":"Phase 1","brief_title":"Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast","source_id_and_acronym":"NCT00788112","lead_sponsor":"University of California, San Francisco","biomarkers":" HDAC6 • HDAC1","pipe":" | ","alterations":" HDAC6 expression","tags":["HDAC6 • HDAC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HDAC6 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Zolinza (vorinostat)"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 07/01/2009","start_date":" 07/01/2009","primary_txt":" Primary completion: 11/03/2011","primary_completion_date":" 11/03/2011","study_txt":" Completion: 08/11/2015","study_completion_date":" 08/11/2015","last_update_posted":"2017-08-07"}]